Cimeio Therapeutics - Transforming Hematopoietic Stem Cell Transplant and Adoptive Cell Therapies

Details:

Details about Cimeio Therapeutics - Transforming Hematopoietic Stem Cell Transplant and Adoptive Cell Therapies

Cimeio is an applied gene editing and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs™ (SCIP), which has the potential to transform hematopoietic stem cell transplant.

Phone

+41612254600

Employees:

Employees at Cimeio Therapeutics - Transforming Hematopoietic Stem Cell Transplant and Adoptive Cell Therapies

Valentin Do Sacramento

Senior Scientist - Cell Therapy - CMC at Cimeio Therapeutics - Transforming Hematopoietic Stem Cell Transplant and Adoptive Cell Therapies

Saniye Yumlu

Associate Director Gene Editing at Cimeio Therapeutics - Transforming Hematopoietic Stem Cell Transplant and Adoptive Cell Therapies

Thomas Fuchs

Chief Executive Officer at Cimeio Therapeutics - Transforming Hematopoietic Stem Cell Transplant and Adoptive Cell Therapies